Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero
Source: SeekingAlpha
2025-10-09 11:33:30 ET
More on Akero Therapeutics, Novo Nordisk, etc.
- Novo Nordisk to Acquire Akero Therapeutics Inc.
- Novo Nordisk A/S (NVO) M&A Call Transcript
- Novo Nordisk: The Lack Of Pricing Power Is A Problem
- Akero Therapeutics soars on $5.2 billion acquisition deal with Novo Nordisk
- Novo Nordisk’s appeal to halt Medicare price negotiations rejected
Read the full article on Seeking Alpha
For further details see:
Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero
Novo Nordisk A/S
NASDAQ: NVO
NVO Trading
3.04% G/L:
$39.7201 Last:
14,038,592 Volume:
$39.19 Open:
NVO Latest News
March 09, 2026 12:44:07 pm
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
March 09, 2026 12:20:00 pm
Novo Nordisk Is Slashing Prices for Ozempic and Wegovy. Here's Why That Might End Up Helping the Stock
NVO Stock Data
$220,548,675,000
4,194,421,000
N/A
749
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
